Keyword results: Lateral Flow

SBI
SBI

SourceBio International – “changes to travel PCR testing are expected to impact”. Uh oh...

Its shares having commenced last week at 166.5p and slipped to a last close 162.5p, today from SourceBio International (SBI) a “Statement re Changes to COVID-19 Travel Testing”…and the shares currently at 137.5p.

ODX
ODX
PREMIUM CONTENT

Will Covid testing be around long enough for companies like Omega Diagnostics to justify their valuations? I doubt it!

I’ve recently found myself wondering how many of these ‘Covid stocks’ have missed the boat, as many of them still aren’t producing any significant amounts of revenue, yet often their markets caps are comparatively very high.

Subscribe to ShareProphets to access Premium Content
Dead-Donkey
PREMIUM CONTENT

A Day is a long time, let alone a Week - how can one be a rational investor in the face of madness?

It was Harold Wilson who said that a week is a long time in politics. It seems now that a day is an eternity. One moment Christmas is all on, the next day it is all off. Yesterday, London and much of the surrounding area were again plunged into crisis: it was placed in Tier 4 of a three tier system  to control Covid-19 – effectively it is in Lockdown 3, only days after Lockdown 2 came to an end. Lockdown 2 must have been a great success then?! I have complained before that it is impossible to run a business under such circumstances – see Tom Winnifrith’s Bearcast yesterday – and consequently, as an investor, investing is made impossible.

Subscribe to ShareProphets to access Premium Content
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Complete Coverage

Recent Comments

|